1994PubMedRequires access

[Anticholinergics and cytoprotectants in gastroduodenal ulcer].

Pasquale Bernardi, Francesco Fidanza, Leonardo Mancini, V Pace

Open publisher page 0 citations

Abstract

The authors evaluate the present curative indications of anticholinergic and cytoprotector drugs in the treatment of ulcer disease. They conclude that the therapeutic relevance of mucosal protective agents is limited in comparison with the major gastroactive medications especially in the treatment of peptic ulcer disease.

About this research paper

What this paper is about

The authors evaluate the present curative indications of anticholinergic and cytoprotector drugs in the treatment of ulcer disease. They conclude that the therapeutic relevance of mucosal protective agents is limited in comparison with the major gastroactive medications especially in the treatment of peptic ulcer disease.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The authors evaluate the present curative indications of anticholinergic and cytoprotector drugs in the treatment of ulcer disease. They conclude that the therapeutic relevance of mucosal protective agents is limited in comparison with the major gastroactive medications especially in the treatment of peptic ulcer disease.

Key concepts: Gastroduodenal ulcer, Medicine, Anticholinergic, Peptic ulcer, Disease, Anticholinergic agents, Gastroenterology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
[Anticholinergics and cytoprotectants in gastroduodenal ulcer]. — Research Paper | ScholarLens